BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2022 1:56:15 PM | Browse: 11 | Download: 11
Publication Name World Journal of Virology
Manuscript ID 80004
Country/Territory Iran
Received
2022-09-13 19:19
Peer-Review Started
2022-09-13 19:21
To Make the First Decision
Return for Revision
2022-10-01 19:09
Revised
2022-10-08 06:50
Second Decision
2022-10-24 03:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-10-28 21:43
Articles in Press
2022-10-28 21:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-11-10 00:57
Publish the Manuscript Online
2022-11-23 13:56
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Potential risk of liver injury in epileptic patients during COVID-19 pandemic
Manuscript Source Invited Manuscript
All Author List Nasim Tabrizi and Athena Sharifi-Razavi
ORCID
Author(s) ORCID Number
Nasim Tabrizi http://orcid.org/0000-0001-7978-2014
Athena Sharifi-Razavi http://orcid.org/0000-0003-3861-9741
Funding Agency and Grant Number
Corresponding Author Athena Sharifi-Razavi, MD, Assistant Professor, Department of Neurology, Mazandaran University of Medical Sciences, Bou Ali Sina Hospital, Pasdaran Boulevard, Sari 4815838477, Iran. athena.sharifi@yahoo.com
Key Words COVID-19; Epilepsy; Seizure; Drug induced liver injury; Corona virus; Hepatic failure
Core Tip Most of antiseizure medications (ASMs) are metabolized in liver and many of them particularly first-generation ASMs have the potential to increase liver enzymes or induce liver injury. Hence, treatment of new onset seizures or epilepsy by ASMs during the course of coronavirus disease 2019 (COVID-19), which could potentially be complicated by hepatic dysfunction, is a challenging clinical issue. In this review, we aimed to discuss the potential risks of liver injury in patients with COVID-19 who are under treatment for epilepsy or need to receive ASMs to subside acute symptomatic seizures.
Publish Date 2022-11-23 13:56
Citation Tabrizi N, Sharifi-Razavi A. Potential risk of liver injury in epileptic patients during COVID-19 pandemic. World J Virol 2022; 11(6): 467-476
URL https://www.wjgnet.com/2220-3249/full/v11/i6/467.htm
DOI https://dx.doi.org/10.5501/wjv.v11.i6.467
Full Article (PDF) WJV-11-467.pdf
Full Article (Word) WJV-11-467.docx
Manuscript File 80004_Auto_Edited-LM.docx
Answering Reviewers 80004-Answering reviewers.pdf
Audio Core Tip 80004-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 80004-Conflict-of-interest statement.pdf
Copyright License Agreement 80004-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 80004-Language certificate.pdf
Peer-review Report 80004-Peer-review(s).pdf
Scientific Misconduct Check 80004-Bing-Fan JR-2.png
Scientific Editor Work List 80004-Scientific editor work list.pdf